Navigation Links
Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for,Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical,Study

SYDNEY, Australia--(BUSINESS WIRE)--Jun 27, 2007 - PrimeCell(TM) Therapeutics LLC (http://www.primecelltherapeutics.com) today announced that it provided research support and pre-clinical studies for a clinical trial to assess the safety, feasibility and efficacy of implanting autologous bone marrow stem cells into spinal cord injury (SCI) patients.

Dr. Luis Geffner presented a preliminary report at the 13th Annual Meeting of the International Society for Cellular Therapy, held here June 24-27. From May 2006 to January 2007, 25 patients with SCI were treated at Luis Vernaza Hospital in Guayaquil, Ecuador. They were treated with autologous bone marrow stem cells - meaning the cells were extracted from the patients' own bone marrow.

Fifteen patients (60 percent) could stand up, ten patients (40 percent) could walk on the parallels with braces, seven (28 percent) could walk without braces, and four (16 percent) could walk with crutches. Patients demonstrated improvements in sensitivity, motility, bladder sensation, even controlling sphincters, erection and ejaculation. No adverse event was observed.

"These preliminary results, while encouraging, must be interpreted cautiously and prudently, and we must continue work examining the benefits of surgically implanted autologous bone marrow stem cells to patients with spinal cord injuries," said Geffner, director of the stem cell program at the Junta de Beneficencia de Guayaquil. He emphasized that this work was done with the help and support of the Junta de Beneficencia, Benemerita Sociedad de Lucha Contra el Cancer (SOLCA), and with the research support and pre-clinical studies performed by stem cell biologist and senior author Francisco Silva and his team at PrimeCell Therapeutics, based in Irvine, Calif.

The study included in vitro (laboratory tests), pre-clinical (animal) and clinical (human) data.

"There is evidence demonstrating signif
'"/>




Page: 1 2

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: ... development and commercialization of products for central nervous ... two posters at the Society for Research on ... The first poster entitled Pleiomorphic ... provides insight into the challenges faced by ...
(Date:5/22/2012)... -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it ... and Drug Administration for its abbreviated new drug ... the generic equivalent of Gynazole·1®. Perrigo was the first ... a paragraph IV certification and is entitled to ... KV Pharmaceutical Company on a collaboration to launch ...
(Date:5/22/2012)... AUSTIN, Texas, May 22, 2012  Prodigy Generics, ... has launched injectable irinotecan. Irinotecan is the generic ... Prodigy partnered with eVenus Pharmaceutical Laboratories ... is the first of several ANDAs being developed ... and exceptional value to the U.S. injectable market, ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3Infant Organ Donors Could Help Meet Transplant Needs 3A Study 78200 1Infant Organ Donors Could Help Meet Transplant Needs 3A Study 78200 2Scripps Research chemist devises new method to quantify protein changes 17165 1Scripps Research chemist devises new method to quantify protein changes 17165 2Scripps Research chemist devises new method to quantify protein changes 17165 3Esperion Therapeutics Initiates Phase 2 Clinical Study for ETC 1002 13706 1Esperion Therapeutics Initiates Phase 2 Clinical Study for ETC 1002 13706 2
(Date:5/23/2012)... research suggests that young asthma patients who use drugs ... -- could be more likely than others to suffer ... increased risk was not seen for some types of ... the recent interest in use of anticholinergics in asthma," ... at Chicago, said in a news release from the ...
(Date:5/23/2012)... treatment with inhaled corticosteroids in patients with respiratory ... associated with a lower incidence and severity of ... researchers in Spain. , A parapneumonic effusion is ... accumulates between the two pleural layers, the fluid-filled ... a result of a pneumonia, lung abscess, or ...
(Date:5/22/2012)... Ill. Magnetic resonance imaging (MRI) provides an ... chemotherapy significantly earlier than possible through clinical examination, ... the journal Radiology . , Women ... surgery. Research has shown that women who receive ... likely to achieve breast conservation than those receiving ...
(Date:5/22/2012)... HealthDay Reporter , , TUESDAY, May 22 (HealthDay News) -- ... common cause of snoring and daytime sleepiness, might also ... the condition -- the risk of developing high blood ... new cases of high blood pressure in two groups ... therapy, or CPAP, for either about four or 11 ...
(Date:5/22/2012)... 22, 2012) -- Researchers at Barrow Neurological Institute ... unveiled how and why the public perceives some ... real-world implications in military tactics, marketing and sports. ... Visual Neuroscience, and Stephen Macknik, PhD, of Barrow,s ... their research into magic and illusions. Their most ...
Breaking Medicine News(10 mins):Health News:Asthma Meds May Be Linked to Irregular Heartbeat 2Health News:Long-term ICS use reduces pleural effusion in patients with CAP 2Health News:Breast MRI helps predict chemotherapy's effectiveness 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 3Health News:Sleep Apnea 'Mask' Might Also Help the Heart 4Health News:Barrow researchers use magic for discoveries 2
... planning to recruit 50,000 people as a part of a large ... relationship // between lifestyle and genetics as regards the health of ... two decades and is one of the largest healthcare projects in ... large pool of information so that it would be easy to ...
... Life of Life Healing Spa is increasingly getting more customers ... the very first session. // Owner Karen Chu claims that ... degree of success since the spa first began offering the ... given here has not yet resulted in any injuries. Most ...
... after eating a single sweet as she suffered from nut ... cream cake but had // failed to identify the chocolate-covered ... and lost consciousness in an hour’s time. She was immediately ... causing irreversible brain damage. , ,Five days later, ...
... and cancer drugs which it hopes will increase its sales ... starting // to market two of its new diabetes drug ... treating type 2 diabetes. ,The drug Avandaryl is ... the drug Avandamet is produced by the combination of Avandina ...
... countrymen safe drinking water within a matter of four ... // to make this possible. Most people living in ... water. ,Inaugurating a conference of ministers ... sanitation in states and union territories, the prime minister ...
... per a study in Tanzania by Duke University Medical Centre, it ... cost effective than charging a small fee for them. // ... free test rather than a charged test. ,The statistics ... a two-week pilot program in 2003. ,The numbers which ...
Other Medicine News:Health News:Safe Drinking Water To Be Made Available 2Health News:Free HIV Tests far more cost effective than small fee 2
... CryoCath has developed a minimally ... reentrant tachycardia. It delivers a very ... site confirmation, pinpoint site precision, minimal ... thrombus and stenosis., ,Freezor Xtra allows ...
... CryoCath has developed a minimally invasive ... tachycardia. It delivers a very high ... confirmation, pinpoint site precision, minimal tissue ... and stenosis., ,Freezor is a flexible, ...
The Medtronic CardioRhythm Marinr Catheter is intended for use in diagnostic electrophysiologic procedures. These catheters are designed for recording intracardiac electrograms and temporary pacing a...
Ten-Ten duodecapolar diagnostic mapping catheters are available in four curve sizes....
Medicine Products: